To confirm the effect of ERK2 SUMOylation on breast cancer cells, we constructed stable MDA-MB-231 cells by lentiviral transduction with wild-type or SUMO site mutant ERK2 plasmids, and the experiments showed similar results (Figures S6A-S6E). This evidence concerns the gene MAPK1 and breast carcinoma.